The central hypothesis of this proposal is that neuronal death (reflected primarily by gray matter volume loss) resulting from demyelination and inflammation-induced axonotomy (rather than myelin loss per se) is the primary factor in induction and progression of physical and neurocognitive disability in patients with multiple sclerosis (MS). We will detect and measure neuronal loss in our well- characterized cohort of MS patients over a 5 year period using magnetic resonance imaging and proton magnetic resonance spectroscopy (1H MRS).
In Specific Aim 1 MS lesions will be assessed by measuring T2 and T1- enhanced lesion volumes and magnetization transfer ratio histogram parameters (MTRHP) in patients with relapsing-remitting and secondary progressive disease. This data will be correlated with total brain parenchymal volume and will be used to characterize the effect of MS lesion on the gray and white matter volumetric components of brain parenchyma. The brain volumetric measurements will be compared to clinical measures of disability including Kurtzke Expanded Disability Status Scale (EDSS) and a specific battery of neuropsychological tests.
Specific Aim 2 includes quantitation of N-acetylaspartate over the whole brain (WBNAA), a reproducible measure of viable neuron number based upon 1H MRS, and comparison of the results to age-matched controls over a duration of 5 years.
Specific Aim 3 is to examine the correlations between the volumetric and clinical measurements in Specific Aim 1 and WBNAA in Specific Aim 2. The techniques that we have developed and validated, which include computerized quantitation of brain parenchyma and the gray and white matter components of parenchyma, analysis of the MTR histogram, and measurement of WBNAA will be utilized to estimate neuronal loss. Additionally we will determine the course of neuronal change over a 5 year duration, and will correlate the markers of neuronal loss with clinical measures of disability. This approach will, for the first time, provide important new data on the full extent of neuronal loss in patients with MS. We feel that these studies will ultimately lead to a more thorough understanding of the natural history of neurodegeneration in MS, and to a more rational design of outcome measures, and patient stratification in MS treatment trials. In addition, these studies will provide a basis for analysis of both primary and secondary central nervous system (CNS) neurodegeneration in other common and devastating disorders such as AIDS dementia complex, Alzheimer's disease and traumatic brain injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37NS029029-12
Application #
6539709
Study Section
Special Emphasis Panel (ZRG1-DMG (06))
Program Officer
Utz, Ursula
Project Start
1991-08-19
Project End
2003-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
12
Fiscal Year
2002
Total Cost
$614,387
Indirect Cost
Name
New York University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Chawla, S; Kister, I; Wuerfel, J et al. (2016) Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI. AJNR Am J Neuroradiol 37:1223-30
Marshall, Olga; Uh, Jinsoo; Lurie, Daniel et al. (2015) The influence of mild carbon dioxide on brain functional homotopy using resting-state fMRI. Hum Brain Mapp 36:3912-21
Chawla, S; Ge, Y; Lu, H et al. (2015) Whole-Brain N-Acetylaspartate Concentration Is Preserved during Mild Hypercapnia Challenge. AJNR Am J Neuroradiol 36:2055-61
Lu, Hanzhang; Liu, Peiying; Yezhuvath, Uma et al. (2014) MRI mapping of cerebrovascular reactivity via gas inhalation challenges. J Vis Exp :
Chang, K; Barnes, S; Haacke, E M et al. (2014) Imaging the effects of oxygen saturation changes in voluntary apnea and hyperventilation on susceptibility-weighted imaging. AJNR Am J Neuroradiol 35:1091-5
Kirov, Ivan I; Tal, Assaf; Babb, James S et al. (2013) Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS. Neurology 80:39-46
Kirov, Ivan I; Tal, Assaf; Babb, James S et al. (2013) Diffuse axonal injury in mild traumatic brain injury: a 3D multivoxel proton MR spectroscopy study. J Neurol 260:242-52
Kirov, Ivan I; Tal, Assaf; Babb, James S et al. (2013) Proton MR spectroscopy correlates diffuse axonal abnormalities with post-concussive symptoms in mild traumatic brain injury. J Neurotrauma 30:1200-4
Kirov, Ivan I; George, Ilena C; Jayawickrama, Nikhil et al. (2012) Longitudinal inter- and intra-individual human brain metabolic quantification over 3 years with proton MR spectroscopy at 3 T. Magn Reson Med 67:27-33
Rigotti, D J; Inglese, M; Kirov, I I et al. (2012) Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis. Neurology 78:1383-9

Showing the most recent 10 out of 77 publications